Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano, +20

Cancer Immunology Research

ImmunologyImmunoeditingPathologyImmune Checkpoint BlockadeImmunotherapy +14

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Mark A. Exley, Phillip Friedlander, Nadia Alatrakchi, +15

Clinical Cancer Research

The Cytosolic Endopeptidase, Thimet Oligopeptidase, Destroys Antigenic Peptides and Limits the Extent of MHC Class I Antigen Presentation

Ian A. York, Annie X. Mo, Kristen Lemerise, +6

Immunity

Destroys Antigenic PeptidesAutoimmune DiseaseAllergyThimet OligopeptidasePathogenesis +8

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells

Ute Burkhardt, Ursula Hainz, Kristen E. Stevenson, +28

Journal of Clinical Investigation

CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients

Linda A. Lieberman, Wanyong Zeng, Carol M. Singh, +7

Neurology

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion

Wandi Zhang, Jaewon Choi, Wanyong Zeng, +10

Clinical Cancer Research

Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens

Wanyong Zeng, Mei Su, Karen S. Anderson, +1

Immunobiology

Tumor ImmunologyCancer ImmunosurveillanceArtificial Antigen-presenting CellsImmunology4-1Bb Ligand +7

Cyclin D1–Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy

Eisei Kondo, Britta Maecker, Martin R. Weihrauch, +5

Clinical Cancer Research

Improving yield-related traits by editing the promoter of the heading date gene Ehd1 in rice

Shengting Li, Yanqiu Luo, Guangliang Wei, +15

Theoretical and Applied Genetics

BiologyPlant GeneticsQuantitative GeneticsMedicineGenetics +11

Identification of human leucocyte antigen (<scp>HLA</scp>)‐A*0201‐restricted cytotoxic <scp>T</scp> lymphocyte epitopes derived from <scp>HLA</scp>‐<scp>DO</scp>β as a novel target for multiple myeloma

Yoon Joong Kang, Wanyong Zeng, Weihua Song, +11

British Journal of Haematology